A look to COVID-19 vaccine from rheumatology

By : Global Rheumatology by PANLAR

18 September, 2020

DOI: https://doi.org/10.46856/grp.232.e040

statistics

751Views

License

This is an open-access article distributed by the terms of the Creative Common Attribution License (CC-BY NC-4). The use, distribution or reproduction in other forms is permitted, provided the original author(a) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with this terms.

To return to the so-called “new normal” the solution is in a COVID-19 vaccine. In the process there are several pharmaceutical companies and an expectant world following the step by step. Where are we with its development? Is it a feasible option for Latin America? When could we use it?

In today’s episode we will talk about these issues with our guest, Dr. Humberto Reynales Londoño, preventive medicine physician, working at the Center of Medical Care and Research (In Spanish, Centro de Atención e Investigación Médica – CAIMED) in Bogota (Colombia), entity with extensive experience in research on vaccination and diseases caused by viruses. We will also be with our host, Dr. Diego Jaimes, and our editor-in-chief, Dr. Carlo Vinicio Caballero.